(Q37850893)

24 August 2017

1 reference

title

Role of tissue plasminogen activator in acute ischemic stroke (English)

1 reference

24 August 2017

1 reference

Molly A Hatcher

1

1 reference

24 August 2017

Jessica A Starr

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

8 March 2011

1 reference

Annals of Pharmacotherapy

24 August 2017

published in

1 reference

24 August 2017

volume

45

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

364-371

1 reference

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

24 August 2017

cites work

1 reference

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci

21 January 2018

1 reference

Primary prevention of ischemic stroke

21 January 2018

1 reference

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

21 January 2018

1 reference

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

21 January 2018

1 reference

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

21 January 2018

1 reference

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

21 January 2018

1 reference

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P525

1 reference

24 August 2017

1 reference